Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis

The purpose of this work was to review and synthesise the evidence on the comparative effectiveness of neutralising monoclonal antibody (nMAB) therapies in individuals exposed to or infected with SARS-CoV-2 and at high risk of developing severe COVID-19. Outcomes of interest were mortality, healthca...

Descripción completa

Detalles Bibliográficos
Autores principales: McConnell, David, Harte, Marie, Walsh, Cathal, Murphy, Desmond, Nichol, Alistair, Barry, Michael, Adams, Roisin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583057/
https://www.ncbi.nlm.nih.gov/pubmed/36266486
http://dx.doi.org/10.1038/s41598-022-22431-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583057/
https://www.ncbi.nlm.nih.gov/pubmed/36266486
http://dx.doi.org/10.1038/s41598-022-22431-6

Ejemplares similares